IVF patients with decreased ovarian response often require controlled ovarian hyperstimulation (COH), resulting in late ovulation trigger and VOR on or after cycle day 16. Patients who require lengthier COH are often viewed as having a poor prognosis, although it is not well established how, independent of oocyte age and ovarian reserve, differences in stimulation duration are predictive of cycle outcome.
with decreased ovarian response (-63 .3 pg/ml estradiol at trigger), oocytes retrieved (-1.1), fertilized (-0.06), blastocysts developed (-0.4) and available for trophectoderm (TE) biopsy (-0.4) and the number of euploid embryos (-0.1) (p<0.0001). Increased cycle day of ovulation trigger was associated with increased odds of not meeting criteria for oocyte retrieval (OR 1.5 [95% CI 1.3-1.7]), <4 oocytes retrieved (OR 1.3 [95% CI 1.2-1.3]), and failed fertilization (OR 1.1 [95% CI 1.1-1.2]) (p<0.0001), with decreased odds of having a blastocyst available for biopsy (OR 0.9 [95% CI 0.8-0.9]) or transfer (OR 0.9 [95% CI 0.8-0.9]) (p<0.0001). However, cycle day of trigger did not influence the odds of having no euploid blastocysts when biopsy was performed (OR 1.0 [95% 0.9-1.1], NS). Controlling for age, number of embryos transferred and ploidy, odds of implantation and early pregnancy loss did not vary with timing of ovulation trigger in the COH cycle.
Conclusions:
Patients who require COH past cycle day 14 are a poor prognosis group, as they are at increased risk of not reaching retrieval, fertilization or blastulation. However, it is encouraging that if these hurdles are overcome, overall embryo quality and competence is not hindered. Based on this data, clinicians can counsel slow-responding patients regarding their IVF prognosis, while reassuring them that blastocysts eligible for biopsy and/or transfer are not an increased risk for failed implantation. Oocytes retrieved 15.4 ± 9.5 9.7 ± 7.4 <0.0001
Support: None
Mean number of day 5 blastocysts 5.1 ± 4.7 2.9 ± 3.7 <0.0001
Mean number of blastocysts biopsied 5.1 ± 4.4 3.5 ± 3.3 <0.0001
Aneuploidy rate 50.3% 49.1% NS
